Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Terminated(1)

Detailed Status

Completed3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
75.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed375%
terminated125%

Recent Activity

0 active trials
Showing 4 of 4
terminatednot_applicable

Electronic Nose Identification of Fasting and Non-fasting Breath Profiles

NCT02419976
completednot_applicable

Can the Electronic Nose Smell COVID-19?

NCT04475562
completednot_applicable

Can the Electronic Nose Smell COVID-19 Antibodies?

NCT04475575
completednot_applicable

Detection of Colorectal Cancer in Patients With a Positive Fecal Immunochemical Test Using an Electronic Nose Device (AeoNoseTM)

NCT03346005

Clinical Trials (4)

Showing 4 of 4 trials
NCT02419976Not Applicable

Electronic Nose Identification of Fasting and Non-fasting Breath Profiles

Terminated
NCT04475562Not Applicable

Can the Electronic Nose Smell COVID-19?

Completed
NCT04475575Not Applicable

Can the Electronic Nose Smell COVID-19 Antibodies?

Completed
NCT03346005Not Applicable

Detection of Colorectal Cancer in Patients With a Positive Fecal Immunochemical Test Using an Electronic Nose Device (AeoNoseTM)

Completed

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4